Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule JC, Chadjichristos CE, Prakoura N, Chatziantoniou C.

J Am Soc Nephrol. 2019 Nov 5. pii: ASN.2019020113. doi: 10.1681/ASN.2019020113. [Epub ahead of print]

PMID:
31690575
2.

Localization and characterization of thyroid microcalcifications: A histopathological study.

Guerlain J, Perie S, Lefevre M, Perez J, Vandermeersch S, Jouanneau C, Huguet L, Frochot V, Letavernier E, Weil R, Rouziere S, Bazin D, Daudon M, Haymann JP.

PLoS One. 2019 Oct 24;14(10):e0224138. doi: 10.1371/journal.pone.0224138. eCollection 2019.

3.

The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept.

Dao M, Lecru L, Vandermeersch S, Ferreira M, Ferlicot S, Posseme K, Dürrbach A, Hermeziu B, Mussini C, Chatziantoniou C, François H.

J Cell Mol Med. 2019 Nov;23(11):7279-7288. doi: 10.1111/jcmm.14570. Epub 2019 Aug 30.

4.

Preventing Calpain Externalization by Reducing ABCA1 Activity with Probenecid Limits Melanoma Angiogenesis and Development.

Hanouna G, Tang E, Perez J, Vandermeersch S, Haymann JP, Baud L, Letavernier E.

J Invest Dermatol. 2019 Aug 16. pii: S0022-202X(19)32702-2. doi: 10.1016/j.jid.2019.06.148. [Epub ahead of print]

PMID:
31425704
5.

Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning.

Le Dudal M, Huguet L, Perez J, Vandermeersch S, Bouderlique E, Tang E, Martori C, Chemaly N, Nabbout R, Haymann JP, Frochot V, Baud L, Deschênes G, Daudon M, Letavernier E.

J Clin Invest. 2019 Apr 4;129(6):2571-2577. doi: 10.1172/JCI99822.

6.

Urothelium proliferation is a trigger for renal crystal deposits in a murine lithogenesis model.

Bilbault H, Perez J, Huguet L, Vandermeersch S, Placier S, Tabibzadeh N, Frochot V, Letavernier E, Bazin D, Daudon M, Haymann JP.

Sci Rep. 2018 Nov 5;8(1):16319. doi: 10.1038/s41598-018-34734-8.

7.

Increased Fatty Acid Oxidation in Differentiated Proximal Tubular Cells Surviving a Reversible Episode of Acute Kidney Injury.

Bataille A, Galichon P, Chelghoum N, Oumoussa BM, Ziliotis MJ, Sadia I, Vandermeersch S, Simon-Tillaux N, Legouis D, Cohen R, Xu-Dubois YC, Commereuc M, Rondeau E, Le Crom S, Hertig A.

Cell Physiol Biochem. 2018;47(4):1338-1351. doi: 10.1159/000490819. Epub 2018 Jun 19.

8.

Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.

Luque Y, Lenoir O, Bonnin P, Hardy L, Chipont A, Placier S, Vandermeersch S, Xu-Dubois YC, Robin B, Lazareth H, Souyri M, Guyonnet L, Baudrie V, Camerer E, Rondeau E, Mesnard L, Tharaux PL.

J Am Soc Nephrol. 2017 Dec;28(12):3563-3578. doi: 10.1681/ASN.2016090960. Epub 2017 Sep 19.

9.

Specific calpain inhibition protects kidney against inflammaging.

Hanouna G, Mesnard L, Vandermeersch S, Perez J, Placier S, Haymann JP, Campagne F, Moroch J, Bataille A, Baud L, Letavernier E.

Sci Rep. 2017 Aug 14;7(1):8016. doi: 10.1038/s41598-017-07922-1.

10.

Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.

Luque Y, Cathelin D, Vandermeersch S, Xu X, Sohier J, Placier S, Xu-Dubois YC, Louis K, Hertig A, Bories JC, Vasseur F, Campagne F, Di Santo JP, Vosshenrich C, Rondeau E, Mesnard L.

Kidney Int. 2017 May;91(5):1146-1158. doi: 10.1016/j.kint.2016.10.037. Epub 2017 Jan 19.

11.

Vancomycin-Associated Cast Nephropathy.

Luque Y, Louis K, Jouanneau C, Placier S, Esteve E, Bazin D, Rondeau E, Letavernier E, Wolfromm A, Gosset C, Boueilh A, Burbach M, Frère P, Verpont MC, Vandermeersch S, Langui D, Daudon M, Frochot V, Mesnard L.

J Am Soc Nephrol. 2017 Jun;28(6):1723-1728. doi: 10.1681/ASN.2016080867. Epub 2017 Jan 12.

12.

Plasma heme-induced renal toxicity is related to a capillary rarefaction.

Tabibzadeh N, Estournet C, Placier S, Perez J, Bilbault H, Girshovich A, Vandermeersch S, Jouanneau C, Letavernier E, Hammoudi N, Lionnet F, Haymann JP.

Sci Rep. 2017 Jan 10;7:40156. doi: 10.1038/srep40156.

13.

Stress Response Gene Nupr1 Alleviates Cyclosporin A Nephrotoxicity In Vivo.

Galichon P, Bataille A, Vandermeersch S, Wetzstein M, Xu-Dubois YC, Legouis D, Hertig A, Buob D, Placier S, Bigé N, Lefevre G, Jouanneau C, Martin C, Iovanna JL, Rondeau E.

J Am Soc Nephrol. 2017 Feb;28(2):545-556. doi: 10.1681/ASN.2015080936. Epub 2016 Jul 22.

14.

Evaluation of the ability of bone marrow derived cells to engraft the kidney and promote renal tubular regeneration in mice following exposure to cisplatin.

Bataille A, Galichon P, Wetzstein M, Legouis D, Vandermeersch S, Rondeau E, Hertig A.

Ren Fail. 2016;38(4):521-9. doi: 10.3109/0886022X.2016.1145521. Epub 2016 Feb 24.

PMID:
26905096
15.

Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression.

Perez J, Dansou B, Hervé R, Levi C, Tamouza H, Vandermeersch S, Demey-Thomas E, Haymann JP, Zafrani L, Klatzmann D, Boissier MC, Letavernier E, Baud L.

J Immunol. 2016 Jan 1;196(1):168-81. doi: 10.4049/jimmunol.1500749. Epub 2015 Nov 25.

16.

Accumulation of GD1α Ganglioside in MDA-MB-231 Breast Cancer Cells Expressing ST6GalNAc V.

Vandermeersch S, Vanbeselaere J, Delannoy CP, Drolez A, Mysiorek C, Guérardel Y, Delannoy P, Julien S.

Molecules. 2015 Apr 16;20(4):6913-24. doi: 10.3390/molecules20046913.

17.

Ex vivo analysis of renal proximal tubular cells.

Legouis D, Bataille A, Hertig A, Vandermeersch S, Simon N, Rondeau E, Galichon P.

BMC Cell Biol. 2015 Mar 25;16:12. doi: 10.1186/s12860-015-0058-4.

18.

Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic?

Letavernier E, Vandermeersch S, Traxer O, Tligui M, Baud L, Ronco P, Haymann JP, Daudon M.

Medicine (Baltimore). 2015 Mar;94(10):e566. doi: 10.1097/MD.0000000000000566.

19.

Cannabinoid receptor 1 is a major mediator of renal fibrosis.

Lecru L, Desterke C, Grassin-Delyle S, Chatziantoniou C, Vandermeersch S, Devocelle A, Vernochet A, Ivanovski N, Ledent C, Ferlicot S, Dalia M, Saïd M, Beaudreuil S, Charpentier B, Vazquez A, Giron-Michel J, Azzarone B, Durrbach A, François H.

Kidney Int. 2015 Jul;88(1):72-84. doi: 10.1038/ki.2015.63. Epub 2015 Mar 11.

20.

An animal model of type A cystinuria due to spontaneous mutation in 129S2/SvPasCrl mice.

Livrozet M, Vandermeersch S, Mesnard L, Thioulouse E, Jaubert J, Boffa JJ, Haymann JP, Baud L, Bazin D, Daudon M, Letavernier E.

PLoS One. 2014 Jul 21;9(7):e102700. doi: 10.1371/journal.pone.0102700. eCollection 2014.

21.

Genetic background-dependent thrombotic microangiopathy is related to vascular endothelial growth factor receptor 2 signaling during anti-glomerular basement membrane glomerulonephritis in mice.

Mesnard L, Cathelin D, Vandermeersch S, Rafat C, Luque Y, Sohier J, Nochy D, Garcon L, Callard P, Jouanneau C, Verpont MC, Tharaux PL, Hertig A, Rondeau E.

Am J Pathol. 2014 Sep;184(9):2438-49. doi: 10.1016/j.ajpath.2014.05.020. Epub 2014 Jul 6.

PMID:
25005449
22.

Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Cathelin D, Placier S, Ploug M, Verpont MC, Vandermeersch S, Luque Y, Hertig A, Rondeau E, Mesnard L.

J Am Soc Nephrol. 2014 Aug;25(8):1662-8. doi: 10.1681/ASN.2013040425. Epub 2014 May 1.

23.

The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma.

Raimbourg Q, Perez J, Vandermeersch S, Prignon A, Hanouna G, Haymann JP, Baud L, Letavernier E.

PLoS One. 2013;8(4):e60469. doi: 10.1371/journal.pone.0060469. Epub 2013 Apr 2.

24.

Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis.

Kerroch M, Guerrot D, Vandermeersch S, Placier S, Mesnard L, Jouanneau C, Rondeau E, Ronco P, Boffa JJ, Chatziantoniou C, Dussaule JC.

FASEB J. 2012 Oct;26(10):4079-91. doi: 10.1096/fj.11-194902. Epub 2012 Jul 2.

PMID:
22751008
25.

Ureteral obstruction promotes proliferation and differentiation of the renal urothelium into a bladder-like phenotype.

Girshovich A, Vinsonneau C, Perez J, Vandermeersch S, Verpont MC, Placier S, Jouanneau C, Letavernier E, Baud L, Haymann JP.

Kidney Int. 2012 Aug;82(4):428-35.

26.

Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction.

Bige N, Shweke N, Benhassine S, Jouanneau C, Vandermeersch S, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Kidney Int. 2012 Jun;81(12):1226-38. doi: 10.1038/ki.2012.21. Epub 2012 Mar 14.

27.

Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.

Bollée G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, Rodenas A, Casal I, Sunnarborg SW, Salant DJ, Kopp JB, Threadgill DW, Quaggin SE, Dussaule JC, Germain S, Mesnard L, Endlich K, Boucheix C, Belenfant X, Callard P, Endlich N, Tharaux PL.

Nat Med. 2011 Sep 25;17(10):1242-50. doi: 10.1038/nm.2491. Erratum in: Nat Med. 2011 Nov;17(11):1521. Nat Med. 2011 Oct;17(10):2 p following 1250.

28.

Epithelial phenotypic changes detect cyclosporine in vivo nephrotoxicity at a reversible stage.

Galichon P, Vittoz N, Xu-Dubois YC, Cornaire E, Vandermeersch S, Mesnard L, Hertig A, Rondeau E.

Transplantation. 2011 Nov 15;92(9):993-8. doi: 10.1097/TP.0b013e31822fa495.

PMID:
21909056
29.

Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis.

Mesnard L, Rafat C, Vandermeersch S, Hertig A, Cathelin D, Xu-Dubois YC, Jouanneau C, Keller AC, Ribeil JA, Leite-de-Moraes MC, Rondeau E.

FASEB J. 2011 Oct;25(10):3543-53. doi: 10.1096/fj.11-180752. Epub 2011 Jul 15.

PMID:
21764994
30.

Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.

Guerrot D, Kerroch M, Placier S, Vandermeersch S, Trivin C, Mael-Ainin M, Chatziantoniou C, Dussaule JC.

Am J Pathol. 2011 Jul;179(1):83-91. doi: 10.1016/j.ajpath.2011.03.023. Epub 2011 May 13.

31.

Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis.

Mesnard L, Keller AC, Michel ML, Vandermeersch S, Rafat C, Letavernier E, Tillet Y, Rondeau E, Leite-de-Moraes MC.

J Am Soc Nephrol. 2009 Jun;20(6):1282-92. doi: 10.1681/ASN.2008040433. Epub 2009 May 21.

32.

Sirolimus interacts with pathways essential for podocyte integrity.

Letavernier E, Bruneval P, Vandermeersch S, Perez J, Mandet C, Belair MF, Haymann JP, Legendre C, Baud L.

Nephrol Dial Transplant. 2009 Feb;24(2):630-8. doi: 10.1093/ndt/gfn574. Epub 2008 Oct 16.

PMID:
18927120
33.

Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.

Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Am J Pathol. 2008 Sep;173(3):631-42. doi: 10.2353/ajpath.2008.080025. Epub 2008 Aug 7.

34.

Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Sabaa N, de Franceschi L, Bonnin P, Castier Y, Malpeli G, Debbabi H, Galaup A, Maier-Redelsperger M, Vandermeersch S, Scarpa A, Janin A, Levy B, Girot R, Beuzard Y, Leboeuf C, Henri A, Germain S, Dussaule JC, Tharaux PL.

J Clin Invest. 2008 May;118(5):1924-33. doi: 10.1172/JCI33308.

35.

Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study.

Ait-Oufella H, Tharaux PL, Baudel JL, Vandermeersch S, Meyer P, Tonnellier M, Dussaule JC, Guidet B, Offenstadt G, Maury E.

Intensive Care Med. 2007 Jul;33(7):1183-1186. doi: 10.1007/s00134-007-0627-x. Epub 2007 Apr 3.

PMID:
17404702
36.

Heparin binding EGF is necessary for vasospastic response to endothelin.

Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, Lee DC, Coffman TM, Richard S, Dussaule JC, Tharaux PL.

FASEB J. 2006 Sep;20(11):1936-8. Epub 2006 Jul 28.

PMID:
16877529
37.

AT1 receptor expression in glomeruli from NO-deficient rats.

Vandermeersch S, Stefanovic V, Hus-Citharel A, Ardaillou R, Dussaule JC, Chansel D.

Nephron Exp Nephrol. 2003;95(3):e119-28.

PMID:
14646364
38.

Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.

Ying L, Flamant M, Vandermeersch S, Boffa JJ, Chatziantoniou C, Dussaule JC, Chansel D.

Hypertension. 2003 Nov;42(5):937-44. Epub 2003 Oct 20.

PMID:
14569001
39.

Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells.

Chansel D, Vandermeersch S, Oko A, Curat C, Ardaillou R.

Eur J Pharmacol. 2001 Mar 2;414(2-3):165-75.

PMID:
11239916
40.

Effects of angiotensin II and antagonists on AT(1) receptor expression in mesangial cells.

Chansel D, Vandermeersch S, Llorens-Cortes C, Ardaillou R.

Eur J Pharmacol. 1999 Nov 19;384(2-3):223-30.

PMID:
10611445
41.

Hemorphins inhibit angiotensin IV binding and interact with aminopeptidase N.

Garreau I, Chansel D, Vandermeersch S, Fruitier I, Piot JM, Ardaillou R.

Peptides. 1998;19(8):1339-48.

PMID:
9809647
42.

Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells.

Chansel D, Czekalski S, Vandermeersch S, Ruffet E, Fournié-Zaluski MC, Ardaillou R.

Am J Physiol. 1998 Oct;275(4):F535-42. doi: 10.1152/ajprenal.1998.275.4.F535.

PMID:
9755125
43.

Modulation by angiotensin II of endothelial cell control of DNA synthesis in human mesangial cells.

Essig M, Dussaule JC, Vandermeersch S, Chatziantoniou C, Ardaillou R.

Nephron. 1997;75(3):303-9.

PMID:
9069452
44.

Protein kinase A activity modulates natriuretic peptide-dependent cGMP accumulation in renal cells.

Ledoux S, Dussaule JC, Chatziantoniou C, Ardaillou N, Vandermeersch S, Ardaillou R.

Am J Physiol. 1997 Jan;272(1 Pt 1):C82-9.

PMID:
9038814
45.

Evidence for angiotensin IV receptors in human collecting duct cells.

Czekalski S, Chansel D, Vandermeersch S, Ronco P, Ardaillou R.

Kidney Int. 1996 Oct;50(4):1125-31.

46.

Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells.

Chansel D, Llorens-Cortes C, Vandermeersch S, Pham P, Ardaillou R.

Hypertension. 1996 Apr;27(4):867-74.

PMID:
8613262
47.

Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.

Chansel D, Bizet T, Vandermeersch S, Pham P, Levy B, Ardaillou R.

Am J Physiol. 1994 Mar;266(3 Pt 2):F384-93.

PMID:
8160786
48.

Characterization of [3H]losartan receptors in isolated rat glomeruli.

Chansel D, Vandermeersch S, Pham P, Ardaillou R.

Eur J Pharmacol. 1993 Oct 15;247(2):193-8.

PMID:
8282008
49.

Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.

Chansel D, Badre L, Czekalski S, Vandermeersch S, Cambar J, Ardaillou R.

J Pharmacol Exp Ther. 1993 Jun;265(3):1534-43.

PMID:
8510026

Supplemental Content

Loading ...
Support Center